Registrant : Organisation or self-employed individual
| Name/company name: |
H. Lundbeck A/S |
| Acronym: |
Hlu
|
| Legal status: |
•internt ansatte repræsentanter og brancheforeninger, der er aktive inden for lobbyvirksomhed
|
| Website address: |
http://www.lundbeck.com/
|
Sections
| Section: |
II - In-house lobbyists and trade/professional associations |
| and more precisely: |
Companies & groups |
Person with legal responsibility
| Surname, Name: |
Ulf Wiinberg
|
| Position: |
CEO |
Permanent person in charge of EU relations
| Surname, Name: |
Neil Mulcock
|
| Position: |
Global Public Affairs Director |
Contact details:
| Contact details of organisation's head office: |
9 Ottiliavej
Valby 2500
DENMARK
|
| Telephone number: |
(+45) 36301311 |
| Fax number: |
(+) |
| Other contact information: |
|
Goals / remit
| Goals / remit of the organisation: |
H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical company highly committed to improve the quality of life for people suffering from disorders in the central nervous system (CNS). For this purpose Lundbeck is engaged in the research and development, production, marketing and sale of pharmaceuticals across the world, targeted at disorders like depression and anxiety, alcohol dependence, schizophrenia, insomnia, Huntington's, Alzheimer's and Parkinson's diseases.
Lundbeck was founded by Hans Lundbeck in 1915 in Copenhagen, Denmark, and today employs 5,900 people worldwide. Lundbeck is one of the world's leading pharmaceutical companies working with CNS disorders. In 2011, the company's revenue was DKK 16.007 billion (approximately EUR 2.0 billion or USD 2.6 billion). For more information, please visit www.lundbeck.com.
|
|
The organisation's fields of interests are:
|
|
Number of persons engaged in activities falling under the scope of the Transparency Register
| Number of persons: |
10
|
|
Complementary information:
|
|
Persons accredited for access to European Parliament premises
Activities
Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:
|
Legislation and public policy areas relevant for the pharmaceutical industry and Lundbecks focus within central neurvous system disorders, eg. mental health
|
Fields of interest for e-mail alerts on consultations and roadmaps;
| Fields declared by the organisation: |
- Employment and Social Affairs
- Enterprise
- Justice and Fundamental Rights
- Public Health
- Research and Technology
|
Networking
Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.
|
Efpia - European Federation of Pharmaceutical Industries and Associations
DI - Confederation of Danish Industry
Lif - The Danish Association of the pharmaceutical industry
Ifpma - International Federation of Pharmaceutical Manufacturers & Associations
|
Financial data
| Financial year: |
01/2011
-
12/2011
|
|
Estimated costs to the organisation directly related to representing interests to EU institutions in that year:
|
400000
€ - 450000
€
|
|
Amount and source of funding received from the EU institutions in financial year n-1 of registration
|
|
Procurement:
|
0 €
|
|
Grants:
|
0 €
|
Other (financial) information provided by the organisation:
|
|
|
